Addus HomeCare Corporation - Common Stock (ADUS)

Revenue climbed 7% alongside a $275 million AccentCare deal.

Home healthcare provider Addus HomeCare (NASDAQ:ADUS) met Wall Street’s revenue expectations in Q3 2026, with sales up 7% year on year to $387.7 million. Its...

Addus HomeCare (NASDAQ:ADUS) reported third-quarter 2026 revenue of $387.7 million, up 7% from $362.3 million in the prior-year period, while adjusted earnings per diluted share rose 17.3% to $1.83. Adjusted EBITDA increased 13.5% to $51.2 million, and the company said its cost discipline and operat

Home healthcare provider Addus HomeCare (NASDAQ:ADUS) met Wall Street’s revenue expectations in Q3 2026, with revenue up 7% year on year to $387.7 million. I...

Home healthcare provider Addus HomeCare (NASDAQ:ADUS) will be reporting earnings this Tuesday after market close. Here’s what to look for. Addus HomeCare met...

A stock with low volatility can be reassuring, but it doesn’t always mean strong long-term performance. Investors who prioritize stability may miss out on hi...

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and...

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...

Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 wil...

As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the senior health, home health & hospice i...

Over the past six months, Addus HomeCare has been a great trade, beating the S&P 500 by 5.7%. Its stock price has climbed to $121.14, representing a healthy ...

Addus HomeCare (NASDAQ:ADUS) reported second-quarter 2026 revenue growth of 8% and adjusted earnings-per-share growth of 16.1%, supported by expansion in personal care and hospice services, improved cash generation and ongoing acquisition activity. Total net service revenues rose to $377.4 million

Home healthcare provider Addus HomeCare (NASDAQ:ADUS) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 8% year on year to $377.4 million. I...

Home healthcare provider Addus HomeCare (NASDAQ:ADUS) will be reporting results this Monday after market hours. Here’s what you need to know. Addus HomeCare ...

Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements...

The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,...

The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how senior health, home he...

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Shareholders who bet on the industry...

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ...

This healthcare provider delivers personal care, hospice, and home health services across 22 states, targeting vulnerable populations.